Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by Dana Publishers
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. vi + 104.
Published by Hyderabad, Apex Books Concern,, 1964
Seller: Mephisto-Antiquariat, Willebadessen, Germany
Book
31 S., In englischer Sprache. Einband unfrisch, wasserwellig, mit Name und Lochung. In English language. Binding with traces of usage, name and perforation. Sprache: Deutsch Gewicht in Gramm: 300 22 cm, brosch. (bound in papers).
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by LAP Lambert Academic Publishing 2012-11, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: Chiron Media, Wallingford, United Kingdom
Book
PF. Condition: New.
Published by LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book Print on Demand
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Metabolic syndrome is a modern era disease which has engulfed wide regions of the world and the problem is increasing at a rapid pace. The atherogenic dyslipidemia associated with the metabolic syndrome predispose to cardiovascular events. The Statins are considered first-line therapy for treating Dyslipidemia. Clinical response to statins is highly variable and genetic factors play an important role. Sterol regulatory element binding factors (SREBF) SREBF Cleavage Activating Protein (SCAP) pathway play important roles in lipid metabolism and homeostasis. Identification of genes & genetic variants that influence statin responsiveness holds promise for a safe and effective treatment of Dyslipidemia in Metabolic syndrome. 160 pp. Englisch.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by LAP Lambert Academic Publishing 2012-09, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: Chiron Media, Wallingford, United Kingdom
Book
PF. Condition: New.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book Print on Demand
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Metabolic syndrome continues to be one of the major causes of mortality and morbidity in populations worldwide with an ever increasing incidence due to dietary and lifestyle changes. Statins are widely prescribed in patients of Metabolic syndrome for treatment of dyslipidemia and other pleiotropic effects. Rosuvastatin also called as superstatin, is a newer analogue with less number of studies especially in the Indian population. This book evaluates whether Rosuvastatin alone, or a combination of Atorvastatin and Ezetimibe would be a better alternative in treating dyslipidemia in patients of Metabolic syndrome. This book is beneficial to both clinicians as well as academicians. It helps the clinicians to choose a better alternative depending on the patient characteristics and helps basic medical scientists to pursue further research in this domain. 164 pp. Englisch.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Metabolic syndrome is a modern era disease which has engulfed wide regions of the world and the problem is increasing at a rapid pace. The atherogenic dyslipidemia associated with the metabolic syndrome predispose to cardiovascular events. The Statins are considered first-line therapy for treating Dyslipidemia. Clinical response to statins is highly variable and genetic factors play an important role. Sterol regulatory element binding factors (SREBF) SREBF Cleavage Activating Protein (SCAP) pathway play important roles in lipid metabolism and homeostasis. Identification of genes & genetic variants that influence statin responsiveness holds promise for a safe and effective treatment of Dyslipidemia in Metabolic syndrome.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Book Print on Demand
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by LAP Lambert Academic Publishing 2011-01, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: Chiron Media, Wallingford, United Kingdom
Book
PF. Condition: New.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Mohammad MisbahuddinDr Misbahuddin MBBS, MD is a Medical Pharmacologist from India. First he joined as junior faculty at Aligarh Muslim University, then KingAbdulaziz University, Saudi Arabia as an Assistant Professor. Dr Misbahuddin.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Metabolic syndrome continues to be one of the major causes of mortality and morbidity in populations worldwide with an ever increasing incidence due to dietary and lifestyle changes. Statins are widely prescribed in patients of Metabolic syndrome for treatment of dyslipidemia and other pleiotropic effects. Rosuvastatin also called as superstatin, is a newer analogue with less number of studies especially in the Indian population. This book evaluates whether Rosuvastatin alone, or a combination of Atorvastatin and Ezetimibe would be a better alternative in treating dyslipidemia in patients of Metabolic syndrome. This book is beneficial to both clinicians as well as academicians. It helps the clinicians to choose a better alternative depending on the patient characteristics and helps basic medical scientists to pursue further research in this domain.
Published by LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book Print on Demand
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: moluna, Greven, Germany
Book Print on Demand
Kartoniert / Broschiert. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Mohammad MisbahuddinDr Misbahuddin is a medical pharmacologist from India. After MBBS and MD, he joined as junior faculty at Aligarh Muslim University. Then he joined King Abdulaziz University, Saudi Arabia as an Assistant Professor.
Published by LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Misbahuddin MirProf. Mir Misbahuddin (b. 1955) is working at the Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Bangladesh since 1993. He obtained his PhD degree from the University of Tokushima, Japan in.
Published by LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - It is a tragedy that there are still 1.5 billion people on this earth has limited access to drinking water. Most of the people are from the developing countries. Another 1.5 billion people are suffering from gastrointestinal diseases due to water-carried pathogens every year. About 3 million people die each year due to gastrointestinal diseases. Arsenic contaminated drinking water is consumed by 50 million people. Five million people are drinking fluoride. Even one million people are consuming lead due to distribution pipes. These pictures are all from the developing countries. In 2002, three-fourth of our total population (72% of the rural population and 82% of the urban population) have the access to safe water. Our focus is on arsenic, fluoride, pesticides, manganese and cyanobacteria.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3838391977ISBN 13: 9783838391977
Seller: dsmbooks, Liverpool, United Kingdom
Book
Paperback. Condition: Like New. Like New. book.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659244724ISBN 13: 9783659244728
Seller: Mispah books, Redhill, SURRE, United Kingdom
Book
Paperback. Condition: Like New. Like New. book.
Published by Springer, 2024
ISBN 10: 9819993229ISBN 13: 9789819993222
Seller: Brook Bookstore, Milano, MI, Italy
Book
Condition: new.
Published by LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3843389691ISBN 13: 9783843389693
Seller: Mispah books, Redhill, SURRE, United Kingdom
Book
Paperback. Condition: Like New. Like New. book.
Published by Springer, 2024
ISBN 10: 9819993229ISBN 13: 9789819993222
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: New.
Published by Springer Verlag, Singapore, Singapore, 2024
ISBN 10: 9819993229ISBN 13: 9789819993222
Seller: Grand Eagle Retail, Wilmington, DE, U.S.A.
Book First Edition
Hardcover. Condition: new. Hardcover. This book introduces different Rare Genetic Disorders (RGDs), and challenges in their diagnosis. The chapters of the book discuss the emerging research and clinical approaches for the diagnosis of rare genetic disorders. It further reviews the future of genetic therapies for the treatment of rare genetic diseases and examine the recent advancements in the field of genetic testing for the diagnosis of these diseases. The book also covers the role of variants in the genome (genetic modifiers) that alleviate (suppress) or exacerbate (enhance) the severity of the disease, resulting in the variability of phenotypic outcomes. Further, the book examines different animal models for critical understanding of disease mechanisms, and the opportunity to evaluate the effect of therapeutic compounds in pre-clinical studies. The subsequent chapters present the state-of-the-art drug discovery strategies and biological approaches for the treatment of rare genetic disorders. Towards the end, the book reviews the current challenges in the diagnosis and treatment of the patients of rare genetic disorders and future opportunities. This book is useful for clinical geneticists, molecular and biochemical geneticists, researchers working in gene therapy and genome editing. This book introduces different Rare Genetic Disorders (RGDs), and challenges in their diagnosis. It further reviews the future of genetic therapies for the treatment of rare genetic diseases and examine the recent advancements in the field of genetic testing for the diagnosis of these diseases. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Published by Springer Nature, 2024
ISBN 10: 9819993229ISBN 13: 9789819993222
Seller: Revaluation Books, Exeter, United Kingdom
Book Print on Demand
Hardcover. Condition: Brand New. 288 pages. 9.25x6.10x9.21 inches. In Stock. This item is printed on demand.